Reply to Ward and Colleagues' Comment on "Using Human Experiments of Nature to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors"

Drug Saf. 2018 Nov;41(11):1101. doi: 10.1007/s40264-018-0701-z.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Humans
  • Proprotein Convertase 9*

Substances

  • PCSK9 protein, human
  • Proprotein Convertase 9